READ & VIEW HERE: https://www.thefocalpoints.com/p/fda-commits-grave-betrayal-fully?utm

On July 10, 2025, the FDA granted full approval for Moderna’s mRNA COVID-19 vaccine (Spikevax) in “at-risk” children aged 6 months to 11 years. The shot was previously available only under emergency use authorization (EUA).